FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Government Shutdown Likely This Weekend

The U.S. government and agencies like FDA headed into the weekend as the ongoing Congressional budgetary impasse was on course to trigger a government...

latest-news-card-1
Medical Devices

FDA Proposed Rule on Lab-Developed Tests

FDA issues a proposed rule to reign in laboratory-developed tests and increase its scrutiny of them due to their growth in use and complexity over man...

latest-news-card-1
Federal Register

Physiologic Closed-Loop Control Guide

Federal Register notice: FDA makes available a final guidance entitled Technical Considerations for Medical Devices with Physiologic Closed-Loop Contr...

latest-news-card-1
Federal Register

Graft-versus-Host Disease Guidance

Federal Register notice: FDA makes available a draft guidance entitled Graft-versus-Host Diseases: Developing Drugs, Biological Products, and Certain ...

latest-news-card-1
Federal Register

De Novo Device E-filing Guide

Federal Register notice: FDA makes available a draft guidance entitled Electronic Submission Template for Medical Device De Novo Requests.

latest-news-card-1
Federal Register

Guide on Device Antimicrobial Testing

Federal Register notice: FDA makes available a final guidance entitled Antimicrobial Susceptibility Test (AST) System Devices Updating Breakpoints in...

latest-news-card-1
Human Drugs

Guide on Drug Dose Banding

FDA posts a final guidance entitled Human Prescription Drug and Biological Products Labeling for Dosing Based on Weight or Body Surface Area for Read...

latest-news-card-1
Biologics

FDA Approves Biogens Actemra Biosimilar

FDA approves a Biogen BLA for Tofidence (tocilizumab-bavi) intravenous formulation, the first biosimilar monoclonal antibody referencing Genentechs ar...

latest-news-card-1
Human Drugs

Generics Office Expands In-person Meetings

CDERs Office of Generic Drugs Office (OGD) expands its post-pandemic return to in-person face-to-face meetings with industry.

latest-news-card-1
Human Drugs

Pilot Seeks to Advance Rare Disease Drugs

FDA announces a new pilot program to further accelerate the development of novel drug and biological products for rare diseases.